Table 3 KEGG pathway enrichment statistics for metabolomics and transcriptomics association analysis
Serial number | Primary access | Secondary access | Pathway description | P value | Number of key metabolites |
|---|---|---|---|---|---|
1 | Organism Systems | Nervous System | Retrograde endogenous cannabinoid signaling | 0.0054 | 2 |
2 | Human Diseases | Infectious Disease: Bacterial | Staphylococcus aureus infection | 0.0118 | 1 |
3 | Human Diseases | Infectious Disease: Bacterial | Pathogenic E. coli infection | 0.0176 | 1 |
4 | Cellular Processes | Transportation and catabolism | Autophagy-Other | 0.0176 | 1 |
5 | Metabolism | Lipid Metabolism | Glyceride Metabolism | 0.0207 | 2 |
6 | Human Diseases | Cardiovascular Disease | Diabetic cardiomyopathy | 0.0218 | 2 |
7 | Cellular Processes | Cell Growth and Death | Apoptosis | 0.0234 | 1 |
8 | Human Disease | Infectious Disease: Viral | Kaposi’s sarcoma-associated herpesvirus infection | 0.0292 | 1 |
9 | Environmental Information Processing | Signal Transduction | FoxO signaling pathway | 0.0292 | 1 |
10 | Metabolism | Carbohydrate Metabolism | Galactose metabolism | 0.0296 | 2 |
11 | Metabolism | Glycine biosynthesis and metabolism | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 0.035 | 1 |
12 | Cellular Processes | Transportation and Catabolism | Autophagy-Animal | 0.035 | 1 |
13 | Human Diseases | Neurodegenerative Diseases | Huntington’s disease | 0.035 | 1 |
14 | Human Diseases | Substance Dependence | Nicotine addiction | 0.0407 | 1 |
15 | Human Diseases | Neurodegenerative diseases | Spinocerebellar ataxia | 0.0407 | 1 |
16 | Organismal Systems | Nervous System | Long-term potentiation | 0.0407 | 1 |
17 | Human Diseases | Substance-dependent | Cocaine addiction | 0.0407 | 1 |
18 | Metabolism | Lipid metabolism | Glycerophospholipid metabolism | 0.0425 | 2 |
19 | Organismal Systems | Nervous system | Glutamatergic synapses | 0.0463 | 1 |
20 | Environmental Information Processing | Membrane transport | ABC transporter protein | 0.0464 | 3 |
